Related Articles
Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus
Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer
Doxorubicin potentiates TRAIL cytotoxicity and apoptosis and can overcome TRAIL-resistance in rhabdomyosarcoma cells
Divergent effects of taurolidine as potential anti-neoplastic agent: Inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo
Evaluation of the safety and efficacy of TRAIL and taurolidine use on human fibrosarcoma xenografts in vivo